GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (STU:JX7) » Definitions » EV-to-FCF

Embecta (STU:JX7) EV-to-FCF : 209.67 (As of Jun. 08, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Embecta's Enterprise Value is €1,886 Mil. Embecta's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was €9 Mil. Therefore, Embecta's EV-to-FCF for today is 209.67.

The historical rank and industry rank for Embecta's EV-to-FCF or its related term are showing as below:

STU:JX7' s EV-to-FCF Range Over the Past 10 Years
Min: -78.87   Med: 9.93   Max: 230.99
Current: 220.72

During the past 5 years, the highest EV-to-FCF of Embecta was 230.99. The lowest was -78.87. And the median was 9.93.

STU:JX7's EV-to-FCF is ranked worse than
94.66% of 356 companies
in the Medical Devices & Instruments industry
Industry Median: 28.035 vs STU:JX7: 220.72

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), Embecta's stock price is €11.30. Embecta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was €1.115. Therefore, Embecta's PE Ratio for today is 10.13.


Embecta EV-to-FCF Historical Data

The historical data trend for Embecta's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta EV-to-FCF Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-FCF
- - - 7.61 52.79

Embecta Quarterly Data
Sep19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.53 36.47 52.79 -80.14 223.53

Competitive Comparison of Embecta's EV-to-FCF

For the Medical Instruments & Supplies subindustry, Embecta's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embecta's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embecta's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Embecta's EV-to-FCF falls into.



Embecta EV-to-FCF Calculation

Embecta's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1885.772/8.994
=209.67

Embecta's current Enterprise Value is €1,886 Mil.
Embecta's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Embecta  (STU:JX7) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Embecta's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.30/1.115
=10.13

Embecta's share price for today is €11.30.
Embecta's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.115.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Embecta EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Embecta's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Embecta (STU:JX7) Business Description

Traded in Other Exchanges
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Embecta (STU:JX7) Headlines

No Headlines